Newly available transcriptome dataset identifies therapeutic targets for neurodegeneration
Lab of Nilüfer Ertekin-Taner Discovers Glial DDR2, STOM, and KANK2 as Therapeutic Targets in Progressive Supranuclear Palsy 🧠 by Zoë Leanza [...]
AD Knowledge Portal at SfN 2023
We will be at SfN in DC in November 2023, exhibiting near the NIH at booth 3313 and answering questions at the following [...]
Understanding the Ingredients for Alzheimer’s disease risk
Researchers from the Jackson Laboratory contribute new scRNA-seq data on microglia in genetically diverse mouse models By [...]
Students Use Agora to Launch Biotech Start-Up for Alzheimer’s Therapeutic
By Zoë Leanza In May 2020, a group of students from the University of Arizona launched a biotechnology start-up called Cliacept (CLEE-a-cept). [...]
Alzforum: Mouse Model LOADs on the Alzheimer’s Risk Factors
Mouse Model LOADs on the Alzheimer’s Risk Factors A new article on Alzforum, Mouse Model LOADs on [...]
MARMO-AD Webinar | Jan 30, 2024 @ 12pm EST
Save the Date: AD Knowledge Portal Webinar Series Jan 30, 2024 | 12pm EST Don't miss the first webinar of the year! Drs. Afonso Silva and Stacey Rizzo will [...]
2023 in Numbers
2023 in Numbers: Celebrating the AD Knowledge Portal's Accomplishments The AD Knowledge Portal and Accelerating Medicines Partnership in Alzheimer’s Disease (AMP-AD) community [...]
AD Knowledge Portal Webinar Series: MARMO-AD
MARMO-AD | Jan 30, 2024 12:00 PM EST Drs. Afonso Silva and Stacey Rizzo will introduce MARMO-AD, a new Open Science consortium that is studying [...]